These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6810289)

  • 1. Long-term treatment of childhood hypertension with captopril.
    Oberfield SE; Rapaport R; Levine LS; New MI
    Pediatr Ann; 1982 Jul; 11(7):614-6, 620-1. PubMed ID: 6810289
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.
    Oberfield SE; Case DB; Levine LS; Rapaport R; Rauh W; New MI
    J Pediatr; 1979 Oct; 95(4):641-4. PubMed ID: 383935
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB; Atlas SA; Marion RM; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
    Friedman A; Chesney RW; Ball D; Goodfriend T
    J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
    Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of arterial blood pressure, plasma renin activity and plasma aldosterone concentration to long-term administration of captopril in patients with severe, treatment-resistant malignant hypertension.
    McCaa CS; Langford HG; Cushman WC; McCaa RE
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():371s-373s. PubMed ID: 396084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in plasma aldosterone during prolonged captopril treatment.
    Lijnen P; Staessen J; Fagard R; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and volume changes associated with captopril.
    Tarazi RC; Bravo EL; Fouad FM; Omvik P; Cody RJ
    Hypertension; 1980; 2(4):576-85. PubMed ID: 6995298
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 11. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effect of captropril in hypertensive patients.
    Johns DW; Baker KM; Ayers CR; Vaughan ED; Carey RM; Peach MJ; Yancey MR; Ortt EM; Williams SC
    Hypertension; 1980; 2(4):567-75. PubMed ID: 6995297
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 14. Active and inactive renin after a single dose of captopril in hypertensive patients.
    Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
    Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril.
    Atkinson AB; Davies DL; Leckie B; Morton JJ; Brown JJ; Fraser R; Lever AF; Robertson JI
    Lancet; 1979 Sep; 2(8143):606-9. PubMed ID: 90271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
    Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
    Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.